Understanding how a specific protein helps a virus replicate.

Characterizing the role of CSDE1 as a critical co-factor for VSV replication.

NIH-funded research Mayo Clinic Rochester · NIH-11030257

This study is looking at how a specific protein in our cells helps the Vesicular Stomatitis Virus (VSV) replicate, and it aims to find out how some cells can resist the virus after being exposed for a long time, which could lead to new ways to treat infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester NIH-funded
Lab location1 site (Rochester, United States)
Project IDNIH-11030257 on NIH RePORTER

What this research studies

This research investigates the role of the CSDE1 protein in the replication of the Vesicular Stomatitis Virus (VSV). By studying how cells can escape viral replication after prolonged exposure to VSV, researchers have identified mutations that affect the virus's ability to replicate. The study employs advanced techniques like RNA sequencing to analyze these mutations and their impact on both the virus and the host cells. This work aims to uncover new insights into viral behavior and potential therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with viral infections or certain types of cancer who may benefit from virotherapy.

Not a fit: Patients with non-viral related conditions or those not affected by cancer may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for viral infections and cancer therapies that utilize viruses to target cancer cells.

How similar studies have performed: Other research has shown promise in using viral therapies for cancer treatment, indicating that this approach may yield beneficial results.

Where this research is happening

Rochester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions cancer antigenscancer virotherapy
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.